Significant cardiac disease complicating Graves’ disease in previously healthy young adults

Autor: Ravikumar Ravindran, N Ubaysekara, S Rice, J K Witczak, Lakdasa Premawardhana, Z Yousef
Jazyk: angličtina
Rok vydání: 2019
Předmět:
Male
Weight loss
Digoxin
Hydrocortisone
Carbimazole
Endocrinology
Diabetes and Metabolism

Graves' disease
Echocardiogram
Cardiomyopathy
Levothyroxine
Pericardial effusion
White
Ibuprofen
January
Radionuclide therapy
lcsh:Diseases of the endocrine glands. Clinical endocrinology
Beta-blockers
0302 clinical medicine
Ramipril
Antibiotics
Lisinopril
Furosemide
Palpitations
FT3
Sinus rhythm
FT4
Tremulousness
Thyroid
Goitre
TSH
Angiography
Atrial fibrillation
Propranolol
Anti-thyroid autoantibodies
Diarrhoea
NSAID
Thyrotoxicosis
Thyroid antibodies
030220 oncology & carcinogenesis
Cardiology
Thyroidectomy
Female
Steroids
medicine.symptom
MRI
Cardiac function curve
Adult
medicine.medical_specialty
Peripheral oedema
Prednisolone
Thyroxine (T4)
030209 endocrinology & metabolism
Cardiomegaly
Heart failure
Thyroid storm
TSH receptor antibodies
X-ray
03 medical and health sciences
Internal medicine
Fluid repletion
Dyspnoea
Internal Medicine
medicine
Hyperhidrosis
Glucocorticoids
Agitation
lcsh:RC648-665
Radiotherapy
business.industry
Triiodothyronine (T3)
medicine.disease
Unique/Unexpected Symptoms or Presentations of a Disease
United Kingdom
Propylthiouracil
Radioiodine
business
Zdroj: Endocrinology, Diabetes & Metabolism Case Reports
Endocrinology, Diabetes & Metabolism Case Reports, Vol 1, Iss 1, Pp 1-6 (2020)
ISSN: 2052-0573
Popis: Summary Graves’ disease is associated with tachydysrythmia, cardiac ischaemia and cardiomyopathy – all uncommon in young adults without previous cardiac disease. We present three young individuals who developed cardiac complications after periods of uncontrolled Graves’ disease. Subject 1: A 34-year-old female had severe thyrotoxic symptoms for weeks. Investigations showed fT4: 98.4 (11–25 pmol/L), fT3: 46.9 (3.1–6.8 pmol/L), TSH 46.1; TSH Learning points: Cardiac complications of Graves’ disease are uncommon in young adults without previous cardiac disease. These complications may however occur if Graves’ disease had been poorly controlled for several weeks or months prior to presentation. Persistent symptoms after adequate control should alert clinicians to the possibility of cardiac disease. Specific treatment of Graves’ disease and appropriate cardiac intervention results in complete recovery in the majority and carries a good prognosis. Early definitive treatment should be offered to them to prevent cardiac decompensation at times of further relapse.
Databáze: OpenAIRE